Betamethasone Dipropionate

Betamethasone Dipropionate

SCHEMBL2271231

CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@@]21C.O=P([O-])([O-])O.[Na+].[Na+]

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Betamethasone Dipropionate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 7/20 0.90
▸ PGR P06401 5/20 0.90
▸ MAPT P10636 3/20 0.90
▸ NR1I2 O75469 2/20 0.90
▸ ADORA3 P0DMS8 2/20 0.90
▸ DRD2 P14416 1/20 0.90
▸ OPRD1 P41143 1/20 0.90
▸ CYP3A4 P08684 6/20 0.76
▸ USP2 O75604 5/20 0.76
▸ LMNA P02545 2/20 0.76
▸ MLNR O43193 1/20 0.76
▸ ABCB11 O95342 1/20 0.76
▸ CYP3A5 P20815 1/20 0.76
▸ PPARG P37231 1/20 0.76
▸ SMN1; SMN2 Q16637 1/20 0.76
▸ NPSR1 Q6W5P4 1/20 0.76
▸ CYP2D6 P10635 1/20 0.76
▸ CYP2C9 P11712 1/20 0.76
▸ HIF1A Q16665 2/20 0.73
▸ CHRM1 P11229 2/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Betamethasone Dipropionate SCHEMBL3836657 0.99 NR3C1 (0.90) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL8584606 0.99 NR3C1 (0.90) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL1479319 0.98 NR3C1 (0.91) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL16213556 0.98 NR3C1 (0.91) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL8419 0.98 NR3C1 (0.91) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL11064031 0.96 NR3C1 (0.86) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL1658520 0.96 NR3C1 (0.88) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL10013893 0.95 NR3C1 (1.00) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL9768468 0.95 NR3C1 (1.00) NR3C1PGRMAPTNR1I2ADORA3
Betamethasone Dipropionate SCHEMBL11429865 0.95 NR3C1 (1.00) NR3C1PGRMAPTNR1I2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041906-A1 METHOD FOR THE PRECIPITATION OF ORGANIC COMPOUNDS FUJI-FILM MANUFACTURING EUROPE B.V. 2010-02-18 — — US claimed
EP-1976608-A1 METHOD FOR THE PRECIPITATION OF ORGANIC COMPOUNDS FUJIFILM Manufacturing Europe B.V. (NL) 2008-10-08 — — EP claimed
WO-2007086735-A1 METHOD FOR THE PRECIPITATION OF ORGANIC COMPOUNDS FUJIFILM MANUFACTURING EUROPE B.V. (NL) 2007-08-02 — — WO claimed
US-20250312425-A1 COMPOSITIONS AND METHODS COMPRISING ADA-1 FOR WOUND HEALING AND VACCINE ENHANCEMENT UNIV DREXEL (US) 2025-10-09 — — US disclosed
US-20240197751-A1 Pharmaceutical composition and use thereof BARNAS, ARIAN JANKUR CAN (AT) 2024-06-20 — — US disclosed
US-11992484-B2 Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief HUTCHISON HEALTH, LLC (US) 2024-05-28 — — US disclosed
US-11992485-B2 Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief HUTCHISON HEALTH, LLC (US) 2024-05-28 — — US disclosed
US-11969432-B2 Pharmaceutical composition and use thereof BARNAS, ARIAN JANKUR CAN (AT) 2024-04-30 — — US disclosed
US-20240115560-A1 SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF HUTCHISON HEALTH, LLC 2024-04-11 — — US disclosed
US-20240115561-A1 SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF HUTCHISON HEALTH, LLC 2024-04-11 — — US disclosed
US-20230218601-A1 ANALGESIC FORMULATIONS AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING AND ENHANCED POSTOPERATIVE PAIN RELIEF HUTCHISON HEALTH, LLC 2023-07-13 — — US disclosed
WO-2007119213-A2 A CULTURE MEDIUM AND PHARMACEUTICAL COMPOSITION FOR REGENERATING CARTILAGE TISSUE, A METHOD, USES AND PRODUCTS RELATED THERETO UNIVERSITA' DEGLI STUDI DI TORINO (IT) 2007-10-25 — — WO disclosed
WO-2007086735-A1 METHOD FOR THE PRECIPITATION OF ORGANIC COMPOUNDS FUJIFILM MANUFACTURING EUROPE B.V. (NL) 2007-08-02 — — WO disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 — — WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 — — WO disclosed
US-6806253-B2 THERAPEUTIC AND PREVENTIVE ANTI-BACTERIAL VACCINE COMPLEX TOROSSIAN FERNAND NARBEY (FR) 2004-10-19 — — US disclosed
US-20020032152-A1 ANTI-HELICOBACTER VACCINE COMPLEX TOROSSIAN FERNAND NARBEY (FR) 2002-03-14 — — US disclosed
EP-0343268-A1 Pharmaceutical composition and process for preparing the same BIOGAL GYOGYSZERGYAR (HU) 1989-11-29 — — EP disclosed
US-4406883-A SHAPES MERRELL DOW PHARMACEUTICALS INC. (US) 1983-09-27 — — US disclosed
US-4292300-A METHYL CELLULOSE, WATER, DRUG INVERESK RESEARCH INTERNATIONAL (GB) 1981-09-29 — — US disclosed
Send feedback